Sarepta Therapeutics | Satış Brüt Kar



Gross Profit On Sales Değişiklik Tarih
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amgen USD 5.54B 430M 2025-03
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Daiichi Sankyo JPY 382.25B 42.1B 2025-06
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Incyte USD 1.14B 151.67M 2025-06
Insmed USD 71.54M 6.75M 2025-03
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Pfizer USD 11.12B 987M 2025-03
PTC Therapeutics USD 196.89M 10.95M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Tectonic Therapeutic 0 0 2025-03
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12


Sarepta Therapeutics Satış Brüt Kar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Aug 2025.